Mark E. Sherman
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Epidemiology top 0.05%
- Cervical Cancer and HPV Research
Papers in
- Epidemiology 97
- Cervical Cancer and HPV Research 96
-
- Ovarian cancer diagnosis and treatment 30
- Co-authors
- MARK H. SCHIFFMAN (59 shared papers)M. Michele Manos (17 shared papers)R. J. Kurman (10 shared papers)Robert J. Kurman (22 shared papers)Allan Hildesheim (35 shared papers)Sholom Wacholder (32 shared papers)J Peto (1 shared paper)Francesc Xavier Bosch (1 shared paper)
- Journals
- Gynecologic Oncology (21 papers)JNCI Journal of the National Cancer Institute (20 papers)Cancer Epidemiology Biomarkers & Prevention (20 papers)The Journal of Infectious Diseases (14 papers)Breast Cancer Research and Treatment (13 papers)
- Partner nations
- United StatesCanadaCosta Rica
In The Last Decade
Mark E. Sherman
370 papers receiving 56.4k citations
Mark E. Sherman's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 4.9k
- Epidemiology 10.9k
- Genetics 2.8k
- Oncology 5.5k
- Obstetrics and Gynecology 1.8k
Countries citing papers authored by Mark E. Sherman
This map shows the geographic impact of Mark E. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Sherman more than expected).
Fields of papers citing papers by Mark E. Sherman
This network shows the impact of papers produced by Mark E. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Sherman. The network helps show where Mark E. Sherman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Sherman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 380 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5244 |
| 2 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 4012 |
| 3 | Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective Hit paper breakdown → | 1995 | 2860 |
| 4 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 5 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2464 |
| 6 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 7 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 8 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 9 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 10 | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 1585 |
| 11 | Association analysis identifies 65 new breast cancer risk loci Hit paper breakdown → | 2017 | 1040 |
| 12 | Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia Hit paper breakdown → | 1993 | 1038 |
| 13 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 824 |
| 14 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Hit paper breakdown → | 2018 | 775 |
| 15 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 768 |
| 16 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 696 |
| 17 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 617 |
| 18 | Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women Hit paper breakdown → | 1994 | 606 |
| 19 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 598 |
| 20 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 580 |
About Mark E. Sherman
Mark E. Sherman is a scholar working on Epidemiology, Reproductive Medicine, Obstetrics and Gynecology, Cancer Research and Oncology, having authored 380 papers that have together received 58.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (96 papers), Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (28 papers), Digital Radiography and Breast Imaging (24 papers), Cancer Risks and Factors (15 papers), Cancer Genomics and Diagnostics (14 papers), BRCA gene mutations in cancer (9 papers) and Breast Cancer Treatment Studies (9 papers). The work is most often cited by research in Cancer Research (4.9k citations), Epidemiology (10.9k citations), Genetics (2.8k citations), Oncology (5.5k citations) and Obstetrics and Gynecology (1.8k citations). Mark E. Sherman has collaborated with scholars based in United States, Canada and Costa Rica. Frequent co-authors include MARK H. SCHIFFMAN, M. Michele Manos, R. J. Kurman, Robert J. Kurman, Allan Hildesheim, Sholom Wacholder, J Peto, Francesc Xavier Bosch, Vı́ctor Moreno and Rolando Herrero. Their work appears in journals such as Gynecologic Oncology, JNCI Journal of the National Cancer Institute, Cancer Epidemiology Biomarkers & Prevention, The Journal of Infectious Diseases and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.